FULGENT GENETICS, INC. Revenues
FULGENT GENETICS, INC. (FLGT) reported Revenues of $5.63 million for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2018-11-09
- FULGENT GENETICS, INC. revenues for the quarter ending 2018-09-30 was $5.63M, a 24.92% increase year-over-year.
- FULGENT GENETICS, INC. revenues for the quarter ending 2018-06-30 was $5.40M, a 16.38% increase year-over-year.
- FULGENT GENETICS, INC. revenues for the quarter ending 2018-03-31 was $4.65M, a 12.31% decline year-over-year.
- FULGENT GENETICS, INC. revenues for the quarter ending 2017-12-31 was $4.28M, a 26.87% decline year-over-year.
- FULGENT GENETICS, INC. revenues for fiscal 2017 was $18.73M, a 2.48% increase from fiscal 2016.
- FULGENT GENETICS, INC. revenues for fiscal 2016 was $18.28M, a 90.85% increase from fiscal 2015.
- FULGENT GENETICS, INC. revenues for fiscal 2015 was $9.58M, a 649.30% increase from fiscal 2014.
- FULGENT GENETICS, INC. revenues for fiscal 2014 was $1.28M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2018-09-30 | $5.63M 10-Q · filed 2018-11-09 | $11.03M derived: sum of 2 quarters · filed 2018-11-09 | $15.68M 10-Q · filed 2018-11-09 | $19.96M derived: sum of 4 quarters · filed 2018-11-09 |
| 2018-06-30 | $5.40M 10-Q · filed 2018-08-13 | $10.05M 10-Q · filed 2018-08-13 | $14.33M derived: sum of 3 quarters · filed 2018-08-13 | $18.84M derived: sum of 4 quarters · filed 2018-11-09 |
| 2018-03-31 | $4.65M 10-Q · filed 2018-05-14 | $8.93M derived: sum of 2 quarters · filed 2018-05-14 | $13.44M derived: sum of 3 quarters · filed 2018-11-09 | $18.08M derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-12-31 | $4.28M 10-K · filed 2018-03-20 | $8.78M derived: sum of 2 quarters · filed 2018-11-09 | $13.42M derived: sum of 3 quarters · filed 2018-11-09 | $18.73M 10-K · filed 2018-03-20 |
| 2017-09-30 | $4.50M 10-Q · filed 2018-11-09 | $9.14M derived: sum of 2 quarters · filed 2018-11-09 | $14.45M 10-Q · filed 2018-11-09 | $20.30M derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | $4.64M 10-Q · filed 2018-08-13 | $9.95M 10-Q · filed 2018-08-13 | $15.80M derived: sum of 3 quarters · filed 2018-08-13 | $20.81M derived: sum of 4 quarters · filed 2018-08-13 |
| 2017-03-31 | $5.31M 10-Q · filed 2018-05-14 | $11.16M derived: sum of 2 quarters · filed 2018-05-14 | $16.17M derived: sum of 3 quarters · filed 2018-05-14 | $20.14M derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | $5.85M 10-K · filed 2018-03-20 | $10.87M derived: sum of 2 quarters · filed 2018-03-20 | $14.84M derived: sum of 3 quarters · filed 2018-03-20 | $18.28M 10-K · filed 2018-03-20 |
| 2016-09-30 | $5.01M 10-K · filed 2018-03-20 | $8.98M derived: sum of 2 quarters · filed 2018-03-20 | $12.42M 10-Q · filed 2017-11-13 | $15.32M derived: sum of 4 quarters · filed 2018-03-20 |
| 2016-06-30 | $3.97M 10-K · filed 2018-03-20 | $7.41M 10-Q · filed 2017-08-14 | $10.31M derived: sum of 3 quarters · filed 2018-03-20 | $13.22M derived: sum of 4 quarters · filed 2018-03-20 |
| 2016-03-31 | $3.44M 10-K · filed 2018-03-20 | $6.34M derived: sum of 2 quarters · filed 2018-03-20 | $9.25M derived: sum of 3 quarters · filed 2018-03-20 | $11.43M derived: sum of 4 quarters · filed 2018-03-20 |
| 2015-12-31 | $2.90M 10-K · filed 2017-03-17 | $5.81M derived: sum of 2 quarters · filed 2017-03-17 | $7.99M derived: sum of 3 quarters · filed 2017-03-17 | $9.58M 10-K · filed 2017-03-17 |
| 2015-09-30 | $2.90M 10-K · filed 2017-03-17 | $5.09M derived: sum of 2 quarters · filed 2017-03-17 | $6.67M 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $2.18M 10-K · filed 2017-03-17 | $3.77M derived: sum of 2 quarters · filed 2017-03-17 | ||
| 2015-03-31 | $1.59M 10-K · filed 2017-03-17 | |||
| 2014-12-31 | $1.28M 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |